Kyverna Therapeutics, Inc. (KYTX)
NASDAQ: KYTX · Real-Time Price · USD
4.120
+0.040 (0.98%)
Nov 20, 2024, 4:00 PM EST - Market closed
Kyverna Therapeutics Analyst Ratings
Total Analysts
5
Consensus Rating
Buy
Price Target
$23.20
Upside
+463.11%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Maintains $7 → $6 | Hold | Maintains | $7 → $6 | +45.63% | Nov 20, 2024 |
| Wells Fargo | Wells Fargo | Buy Maintains $44 → $24 | Buy | Maintains | $44 → $24 | +482.52% | Nov 15, 2024 |
| UBS | UBS | Strong Buy Initiates $13 | Strong Buy | Initiates | $13 | +215.53% | Oct 10, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $7 | Hold | Reiterates | $7 | +69.90% | Sep 19, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Maintains $8 → $7 | Hold | Maintains | $8 → $7 | +69.90% | Aug 15, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $39 → $33 | Buy | Maintains | $39 → $33 | +700.97% | Jul 31, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $8 | Hold | Reiterates | $8 | +94.17% | Jul 16, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Initiates $8 | Hold | Initiates | $8 | +94.17% | Jul 3, 2024 |
| JP Morgan | JP Morgan | Buy Initiates $39 | Buy | Initiates | $39 | +846.60% | Mar 4, 2024 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $40 | Buy | Initiates | $40 | +870.87% | Mar 4, 2024 |